HPV-positive oropharyngeal cancer patients nearly twice as likely to survive as HPV-negative patients

A retrospective analysis of oropharyngeal patients with recurrence of disease after primary therapy found that HPV-positive patients had a higher overall survival rate than HPV-negative patients (at two years post-treatment, 54.6 percent vs. 27.6 percent, respectively), according to research.

Read the whole article on Science Daily

More from Science Daily